Diabetes and outcomes after radical prostatectomy: Are results affected by obesity and race? Results from the shared equal-access regional cancer hospital database

Jayakrishnan Jayachandran, William J. Aronson, Martha K. Terris, Joseph C. Presti, Christopher L. Amling, Christopher J. Kane, Stephen J. Freedland

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Background: Diabetes is associated with lower prostate cancer risk. The association of diabetes with prostate cancer outcomes is less clear. We examined the association between diabetes and outcomes after radical prostatectomy and tested whether associations varied by race and/or obesity. Materials and Methods: This study is a retrospective analysis of 1,262 men treated with radical prostatectomy between 1988 and 2008 within the Shared Equal-Access Regional Cancer Hospital database. We examined the multivariate association between diabetes at surgery and adverse pathology, biochemical recurrence (BCR), and prostate-specific antigen doubling time at recurrence using logistic, proportional hazards, and linear regression, respectively. Data were examined as a whole and stratified by race and obesity. Results: Diabetes was more prevalent among black (22% versus 15%, P < 0.001) and more obese men (P < 0.001). Diabetes was associated with higher tumor grade (odds ratio, 1.73; P = 0.002), seminal vesicle invasion (odds ratio, 1.73; P = 0.04), but not BCR (P = 0.67) or PSADT at recurrence (P = 0.12). In the secondary analysis, among white obese men, diabetes was associated with 2.5-fold increased BCR risk (P = 0.002) and a trend toward shorter PSADT, whereas among all other men (nonobese white men and black men), diabetes was associated with 23% lower recurrence risk (P = 0.09) and longer PSADT (P = 0.04). Conclusion: In a radical prostatectomy cohort, diabetes was not associated with BCR. In the secondary analysis, diabetes was associated with more aggressive disease in obese white men and less aggressive disease for all other subsets. If externally validated, these findings suggest that among men with prostate cancer, the association between diabetes and prostate cancer aggressiveness may vary by race and obesity.

Original languageEnglish (US)
Pages (from-to)9-17
Number of pages9
JournalCancer Epidemiology Biomarkers and Prevention
Volume19
Issue number1
DOIs
StatePublished - Jan 1 2010

Fingerprint

Cancer Care Facilities
Prostatectomy
Obesity
Databases
Recurrence
Prostatic Neoplasms
Odds Ratio
Seminal Vesicles
Prostate-Specific Antigen
Linear Models
Pathology

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Cite this

Diabetes and outcomes after radical prostatectomy : Are results affected by obesity and race? Results from the shared equal-access regional cancer hospital database. / Jayachandran, Jayakrishnan; Aronson, William J.; Terris, Martha K.; Presti, Joseph C.; Amling, Christopher L.; Kane, Christopher J.; Freedland, Stephen J.

In: Cancer Epidemiology Biomarkers and Prevention, Vol. 19, No. 1, 01.01.2010, p. 9-17.

Research output: Contribution to journalArticle

Jayachandran, Jayakrishnan ; Aronson, William J. ; Terris, Martha K. ; Presti, Joseph C. ; Amling, Christopher L. ; Kane, Christopher J. ; Freedland, Stephen J. / Diabetes and outcomes after radical prostatectomy : Are results affected by obesity and race? Results from the shared equal-access regional cancer hospital database. In: Cancer Epidemiology Biomarkers and Prevention. 2010 ; Vol. 19, No. 1. pp. 9-17.
@article{7db6ad391dd5445592b4c57fe461e769,
title = "Diabetes and outcomes after radical prostatectomy: Are results affected by obesity and race? Results from the shared equal-access regional cancer hospital database",
abstract = "Background: Diabetes is associated with lower prostate cancer risk. The association of diabetes with prostate cancer outcomes is less clear. We examined the association between diabetes and outcomes after radical prostatectomy and tested whether associations varied by race and/or obesity. Materials and Methods: This study is a retrospective analysis of 1,262 men treated with radical prostatectomy between 1988 and 2008 within the Shared Equal-Access Regional Cancer Hospital database. We examined the multivariate association between diabetes at surgery and adverse pathology, biochemical recurrence (BCR), and prostate-specific antigen doubling time at recurrence using logistic, proportional hazards, and linear regression, respectively. Data were examined as a whole and stratified by race and obesity. Results: Diabetes was more prevalent among black (22{\%} versus 15{\%}, P < 0.001) and more obese men (P < 0.001). Diabetes was associated with higher tumor grade (odds ratio, 1.73; P = 0.002), seminal vesicle invasion (odds ratio, 1.73; P = 0.04), but not BCR (P = 0.67) or PSADT at recurrence (P = 0.12). In the secondary analysis, among white obese men, diabetes was associated with 2.5-fold increased BCR risk (P = 0.002) and a trend toward shorter PSADT, whereas among all other men (nonobese white men and black men), diabetes was associated with 23{\%} lower recurrence risk (P = 0.09) and longer PSADT (P = 0.04). Conclusion: In a radical prostatectomy cohort, diabetes was not associated with BCR. In the secondary analysis, diabetes was associated with more aggressive disease in obese white men and less aggressive disease for all other subsets. If externally validated, these findings suggest that among men with prostate cancer, the association between diabetes and prostate cancer aggressiveness may vary by race and obesity.",
author = "Jayakrishnan Jayachandran and Aronson, {William J.} and Terris, {Martha K.} and Presti, {Joseph C.} and Amling, {Christopher L.} and Kane, {Christopher J.} and Freedland, {Stephen J.}",
year = "2010",
month = "1",
day = "1",
doi = "10.1158/1055-9965.EPI-09-0777",
language = "English (US)",
volume = "19",
pages = "9--17",
journal = "Cancer Epidemiology Biomarkers and Prevention",
issn = "1055-9965",
publisher = "American Association for Cancer Research Inc.",
number = "1",

}

TY - JOUR

T1 - Diabetes and outcomes after radical prostatectomy

T2 - Are results affected by obesity and race? Results from the shared equal-access regional cancer hospital database

AU - Jayachandran, Jayakrishnan

AU - Aronson, William J.

AU - Terris, Martha K.

AU - Presti, Joseph C.

AU - Amling, Christopher L.

AU - Kane, Christopher J.

AU - Freedland, Stephen J.

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Background: Diabetes is associated with lower prostate cancer risk. The association of diabetes with prostate cancer outcomes is less clear. We examined the association between diabetes and outcomes after radical prostatectomy and tested whether associations varied by race and/or obesity. Materials and Methods: This study is a retrospective analysis of 1,262 men treated with radical prostatectomy between 1988 and 2008 within the Shared Equal-Access Regional Cancer Hospital database. We examined the multivariate association between diabetes at surgery and adverse pathology, biochemical recurrence (BCR), and prostate-specific antigen doubling time at recurrence using logistic, proportional hazards, and linear regression, respectively. Data were examined as a whole and stratified by race and obesity. Results: Diabetes was more prevalent among black (22% versus 15%, P < 0.001) and more obese men (P < 0.001). Diabetes was associated with higher tumor grade (odds ratio, 1.73; P = 0.002), seminal vesicle invasion (odds ratio, 1.73; P = 0.04), but not BCR (P = 0.67) or PSADT at recurrence (P = 0.12). In the secondary analysis, among white obese men, diabetes was associated with 2.5-fold increased BCR risk (P = 0.002) and a trend toward shorter PSADT, whereas among all other men (nonobese white men and black men), diabetes was associated with 23% lower recurrence risk (P = 0.09) and longer PSADT (P = 0.04). Conclusion: In a radical prostatectomy cohort, diabetes was not associated with BCR. In the secondary analysis, diabetes was associated with more aggressive disease in obese white men and less aggressive disease for all other subsets. If externally validated, these findings suggest that among men with prostate cancer, the association between diabetes and prostate cancer aggressiveness may vary by race and obesity.

AB - Background: Diabetes is associated with lower prostate cancer risk. The association of diabetes with prostate cancer outcomes is less clear. We examined the association between diabetes and outcomes after radical prostatectomy and tested whether associations varied by race and/or obesity. Materials and Methods: This study is a retrospective analysis of 1,262 men treated with radical prostatectomy between 1988 and 2008 within the Shared Equal-Access Regional Cancer Hospital database. We examined the multivariate association between diabetes at surgery and adverse pathology, biochemical recurrence (BCR), and prostate-specific antigen doubling time at recurrence using logistic, proportional hazards, and linear regression, respectively. Data were examined as a whole and stratified by race and obesity. Results: Diabetes was more prevalent among black (22% versus 15%, P < 0.001) and more obese men (P < 0.001). Diabetes was associated with higher tumor grade (odds ratio, 1.73; P = 0.002), seminal vesicle invasion (odds ratio, 1.73; P = 0.04), but not BCR (P = 0.67) or PSADT at recurrence (P = 0.12). In the secondary analysis, among white obese men, diabetes was associated with 2.5-fold increased BCR risk (P = 0.002) and a trend toward shorter PSADT, whereas among all other men (nonobese white men and black men), diabetes was associated with 23% lower recurrence risk (P = 0.09) and longer PSADT (P = 0.04). Conclusion: In a radical prostatectomy cohort, diabetes was not associated with BCR. In the secondary analysis, diabetes was associated with more aggressive disease in obese white men and less aggressive disease for all other subsets. If externally validated, these findings suggest that among men with prostate cancer, the association between diabetes and prostate cancer aggressiveness may vary by race and obesity.

UR - http://www.scopus.com/inward/record.url?scp=74549196089&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=74549196089&partnerID=8YFLogxK

U2 - 10.1158/1055-9965.EPI-09-0777

DO - 10.1158/1055-9965.EPI-09-0777

M3 - Article

C2 - 20056618

AN - SCOPUS:74549196089

VL - 19

SP - 9

EP - 17

JO - Cancer Epidemiology Biomarkers and Prevention

JF - Cancer Epidemiology Biomarkers and Prevention

SN - 1055-9965

IS - 1

ER -